teprotide has been researched along with Heart Failure in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 35 (97.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (2.78) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atlas, SA; Case, DB; Cody, RJ; Laragh, JH | 1 |
| Cohn, JN; Vrobel, TR | 1 |
| Coffman, JD; Creager, MA; Faxon, DP; Gavras, H; Halperin, JL; Ryan, TJ | 1 |
| Dipalma, JR | 1 |
| Bodem, G; Ochs, HR | 1 |
| Brunner, H; Charocopos, F; Gavras, H; Gavras, I | 1 |
| Alexander, RW; Braunwald, E; Colucci, WS; Williams, GH | 1 |
| Goldstein, DS | 1 |
| Hollenberg, NK | 1 |
| Cohn, JN; Levine, TB | 2 |
| Brunner, HR; Turini, GA | 1 |
| Bass, TA; Creager, MA; Faxon, DP; Gavras, H; Halperin, JL; Melidossian, CD; Ryan, TJ | 1 |
| Froer, KL; Hall, D; Rudolf, W | 1 |
| Cody, RJ; Covit, AB; Laragh, JH; Schaer, GL | 1 |
| Sullivan, JM | 1 |
| Assey, ME; Gazes, PC | 1 |
| Bolli, P; Bühler, FR | 1 |
| Bernard, DB; Creager, MA; Faxon, DP; Halperin, JL; Ryan, TJ | 1 |
| Cody, RJ | 1 |
| Materson, BJ | 1 |
| Brunner, HR; Gavras, H | 1 |
| Cohn, JN; Levine, TB; Mashiro, I; Mehta, J | 1 |
| Armstrong, PW | 1 |
| Cohn, JN; Curtiss, C; Franciosa, JA; Vrobel, T | 1 |
| Berkoben, J; Brunner, HR; Faxon, DP; Gavras, H; Ryan, TJ | 1 |
| Robertson, JI | 1 |
| Fouad, FM; Tarazi, RC | 1 |
| Pitt, B | 1 |
| Franciosa, JA; Jordan, RA; Wilen, MM | 1 |
| Ferguson, RK; Riley, LJ; Vlasses, PH | 1 |
| Jia, L | 1 |
| Crozier, IG; Ikram, H; Lewis, GR; Nicholls, MG; Richards, AM; Webster, MW | 1 |
| Aarsland, T; Dickstein, K | 1 |
| Dickstein, K | 1 |
| Riegger, AJ | 1 |
12 review(s) available for teprotide and Heart Failure
| Article | Year |
|---|---|
Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Drug Tolerance; Enzyme Inhibitors; Heart Failure; Humans; Hydralazine; Nitrates; Nitroprusside; Oligopeptides; Parasympatholytics; Phenoxybenzamine; Phentolamine; Prazosin; Teprotide; Vasodilator Agents | 1981 |
The role of hormones in congestive heart failure: new frontiers in therapy?
Topics: Animals; Antihypertensive Agents; Captopril; Dogs; Guinea Pigs; Heart Failure; Humans; Renin; Renin-Angiotensin System; Saralasin; Teprotide | 1982 |
[New drug preparations used for treating congestive heart failure: converting enzyme inhibitors, nitroprusside, nitrates and calcium channel blockers].
Topics: Calcium Channel Blockers; Captopril; Dose-Response Relationship, Drug; Ferricyanides; Heart Failure; Hemodynamics; Humans; Nitrates; Nitroprusside; Oligopeptides; Teprotide; Time Factors | 1982 |
Drug suppression of the angiotensin system in congestive heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Renin-Angiotensin System; Saralasin; Teprotide | 1983 |
[Therapy of hypertensive heart disease: vasodilator agents in the forefront].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Heart Failure; Humans; Hypertension; Oligopeptides; Teprotide; Vasodilator Agents | 1984 |
Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Captopril; Dipeptides; Enalapril; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertension, Pulmonary; Kinetics; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Renin; Renin-Angiotensin System; Teprotide | 1984 |
Monotherapy of hypertension with angiotensin-converting enzyme inhibitors.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dipeptides; Enalapril; Heart Failure; Humans; Hypertension; Proline; Racial Groups; Teprotide; Time Factors | 1984 |
Role of angiotensin and its inhibition in hypertension, ischemic heart disease, and heart failure.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Coronary Circulation; Heart Failure; Hemodynamics; Humans; Hypertension; Male; Myocardial Ischemia; Renin; Renin-Angiotensin System; Saralasin; Teprotide | 2001 |
Role of vasoconstrictor mechanisms in the control of left ventricular performance of the normal and damaged heart.
Topics: Animals; Captopril; Cardiography, Impedance; Dogs; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hypertension; Phenylephrine; Plethysmography, Impedance; Renin; Stroke Volume; Teprotide; Vasoconstriction | 1979 |
Clinical pharmacology and therapeutic applications of the new oral converting enzyme inhibitor, enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Dipeptides; Enalapril; Heart Failure; Hemodynamics; Humans; Hyperaldosteronism; Hypertension; Kinetics; Oligopeptides; Renin; Teprotide | 1985 |
[Some advances in angiotensin converting enzyme inhibitors].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Heart Failure; Humans; Hypertension; Oligopeptides; Prostaglandins; Scleroderma, Systemic; Structure-Activity Relationship; Teprotide | 1985 |
Practical guidelines for the use of converting enzyme inhibitors in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Creatinine; Enzyme Inhibitors; Heart Failure; Humans; Hypotension, Orthostatic; Oligopeptides; Potassium; Teprotide | 1987 |
2 trial(s) available for teprotide and Heart Failure
| Article | Year |
|---|---|
Monotherapy of hypertension with angiotensin-converting enzyme inhibitors.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dipeptides; Enalapril; Heart Failure; Humans; Hypertension; Proline; Racial Groups; Teprotide; Time Factors | 1984 |
Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure.
Topics: Adult; Aged; Body Weight; Dipeptides; Double-Blind Method; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Oligopeptides; Physical Exertion; Renin; Teprotide | 1985 |
23 other study(ies) available for teprotide and Heart Failure
| Article | Year |
|---|---|
Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arterioles; Captopril; Enalapril; Enalaprilat; Heart Failure; Humans; Hypertension; Kinetics; Male; Nifedipine; Renin; Renin-Angiotensin System; Sodium; Teprotide; Vascular Resistance | 1983 |
Comparative hemodynamic effects of converting enzyme inhibitor and sodium nitroprusside in severe heart failure.
Topics: Cardiac Output; Enzyme Inhibitors; Ferricyanides; Heart Failure; Heart Rate; Hemodynamics; Humans; Nitroprusside; Norepinephrine; Oligopeptides; Oxygen; Renin; Teprotide | 1980 |
Central and peripheral hemodynamic effects of angiotensin inhibition in patients with refractory congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Female; Heart Failure; Hemodynamics; Humans; Leg; Male; Middle Aged; Norepinephrine; Oligopeptides; Pulmonary Circulation; Renin; Teprotide; Vascular Resistance | 1980 |
Angiotensin-converting enzyme inhibitors.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans; Hypertension; Oligopeptides; Proline; Renin; Teprotide | 1980 |
[Alternatives to digitalis therapy?].
Topics: Albuterol; Captopril; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Teprotide | 1981 |
Angiotensin converting enzyme inhibition: a new therapeutic modality.
Topics: Captopril; Heart Failure; Humans; Hypertension; Oligopeptides; Proline; Teprotide | 1981 |
Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Diazepam; Drug Interactions; Heart Failure; Heart Ventricles; Humans; Hypertension; Myocardial Infarction; Nitroprusside; Norepinephrine; Physical Exertion; Propranolol; Stress, Physiological; Sympathetic Nervous System; Teprotide; Ventricular Fibrillation | 1981 |
Renal response to angiotensin-converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Dogs; Glomerular Filtration Rate; Heart Failure; Humans; Hypertension; Kinins; Rabbits; Rats; Renal Circulation; Renin-Angiotensin System; Saralasin; Sodium; Teprotide; Water-Electrolyte Balance | 1982 |
Angiotensin-converting enzyme inhibition in congestive heart failure: the concept.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Creatinine; Heart Failure; Hemodynamics; Humans; Norepinephrine; Oligopeptides; Proline; Renin; Renin-Angiotensin System; Sodium; Teprotide; Water-Electrolyte Balance | 1982 |
Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Catheterization; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Oligopeptides; Proline; Renin; Teprotide; Vasodilator Agents | 1982 |
Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Coronary Circulation; Coronary Disease; Coronary Vessels; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Oligopeptides; Oxygen Consumption; Proline; Renin-Angiotensin System; Stroke Volume; Teprotide; Vascular Resistance | 1982 |
Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure.
Topics: Administration, Oral; Aged; Chronic Disease; Dipeptides; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Hypotension, Orthostatic; Long-Term Care; Male; Middle Aged; Oligopeptides; Saralasin; Teprotide; Time Factors | 1983 |
The management of congestive heart failure.
Topics: Aged; Arrhythmias, Cardiac; Calcium Channel Blockers; Captopril; Cardiac Output; Cardiotonic Agents; Digitalis Glycosides; Diuretics; Echocardiography; Female; Heart Failure; Heart Transplantation; History, 17th Century; Humans; Middle Aged; Nitroprusside; Teprotide; Vasodilator Agents | 1984 |
Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Output; Coronary Circulation; Forearm; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Oligopeptides; Proline; Regional Blood Flow; Renal Circulation; Renin; Renin-Angiotensin System; Splanchnic Circulation; Teprotide; Vascular Resistance | 1984 |
Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure.
Topics: Chronic Disease; Dobutamine; Dopamine; Heart; Heart Failure; Hemodynamics; Humans; Hydralazine; Monitoring, Physiologic; Nitrates; Nitroprusside; Phentolamine; Prazosin; Teprotide; Vasodilator Agents | 1979 |
Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.
Topics: Adult; Aged; Angiotensin II; Blood Pressure; Cardiac Output; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Pulmonary Circulation; Renin; Teprotide; Vascular Resistance; Vasoconstriction | 1978 |
Angiotensin converting enzyme inhibition in patients with congestive heart failure.
Topics: Aged; Blood Pressure; Cardiac Output; Coronary Circulation; Drug Evaluation; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Oligopeptides; Oxygen Consumption; Pulmonary Circulation; Stroke Volume; Teprotide; Vascular Resistance | 1978 |
Circulatory basis for the use of angiotensin converting enzyme inhibitors in hypertension and cardiac failure.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Benzothiadiazines; Blood Pressure; Diuretics; Dogs; Enalapril; Enzyme Inhibitors; Heart Failure; Humans; Hypertension; Hypertension, Renovascular; Kidney; Oligopeptides; Rats; Renal Circulation; Renin-Angiotensin System; Sodium Chloride Symporter Inhibitors; Teprotide | 1986 |
Restoration of cardiac function and structure by converting enzyme inhibition possibilities and limitations of long-term treatment in hypertension and heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomegaly; Coronary Circulation; Enalapril; Heart; Heart Failure; Heart Ventricles; Humans; Hypertension; Oligopeptides; Rats; Teprotide | 1986 |
Natural history of patients with congestive heart failure. Potential role of converting enzyme inhibitors in improving survival.
Topics: Angiotensin-Converting Enzyme Inhibitors; Death, Sudden; Electrolytes; Heart Failure; Hemodynamics; Humans; Neurotransmitter Agents; Oligopeptides; Prognosis; Teprotide | 1986 |
Combined spironolactone and converting-enzyme inhibitor therapy for refractory heart failure.
Topics: Adult; Captopril; Diuresis; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Male; Middle Aged; Oligopeptides; Spironolactone; Teprotide | 1986 |
[Angiotensin-converting enzyme inhibitor in heart failure].
Topics: Dose-Response Relationship, Drug; Heart Failure; Humans; Oligopeptides; Teprotide | 1987 |
Role of vasopressin in experimental heart failure.
Topics: Animals; Aortic Valve Stenosis; Arginine Vasopressin; Blood Pressure; Captopril; Disease Models, Animal; Dogs; Heart Failure; Pulmonary Valve Stenosis; Rats; Renin-Angiotensin System; Teprotide; Water-Electrolyte Balance | 1988 |